Kathleen M. Carroll, Ph.D., recently named Albert E. Kent Professor of Psychiatry, studies behavioral, pharmacological, and combined treatments for addiction, with an emphasis on improving the quality of such therapies through rigorous research on their clinical efficacy.

Carroll graduated summa cum laude from Duke University, completed predoctoral training in the Yale Department of Psychiatry’s Division of Substance Abuse, and earned her Ph.D. in clinical psychology from the University of Minnesota. She joined the Yale faculty in 1990, becoming full professor in 2002.

Carroll is the principal investigator of the School of Medicine’s Psychotherapy Development Research Center—the only National Institute on Drug Abuse (NIDA) center devoted to behavioral therapies research—and of the New England node of NIDA’s Clinical Trials Network. She received a MERIT Award from the National Institutes of Health in 2003 for her research on computer-assisted training in cognitive-behavioral therapy.

Carroll has been designated as a Highly Cited Researcher by ISI Thompson, and she is the author of more than 220 peer-reviewed research publications as well as numerous books and book chapters.

Carroll was president of the American Psychological Association’s Division 50 (Addictions) from 2002 to 2005, when she received the Division’s Distinguished Scientific Contributions to Education and Training Award.